Variant report
Variant | nsv518754 |
---|---|
Chromosome Location | chr14:40564004-40572241 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:40570496..40572299-chr14:40575193..40577238,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576573198 | chr14:40566404-40566405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs537528183 | chr14:40566426-40566427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs538887575 | chr14:40566427-40566428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs186079964 | chr14:40566438-40566439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs572415293 | chr14:40566444-40566445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146436703 | chr14:40566470-40566471 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs560900582 | chr14:40566475-40566476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs529182849 | chr14:40566489-40566490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs550804730 | chr14:40566511-40566512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs71130880 | chr14:40566523-40566524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs574046625 | chr14:40566524-40566525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs71130881 | chr14:40566554-40566555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs8019403 | chr14:40566573-40566574 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs374546884 | chr14:40566580-40566581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs8019316 | chr14:40566636-40566637 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs118063228 | chr14:40566644-40566645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs17196 | chr14:40566655-40566656 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs559524333 | chr14:40566727-40566728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs528147990 | chr14:40566741-40566742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs8020777 | chr14:40566754-40566755 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs189620942 | chr14:40566777-40566778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs568051921 | chr14:40566830-40566831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs571449328 | chr14:40566869-40566870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs182695783 | chr14:40566894-40566895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs537087997 | chr14:40566901-40566902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs550425018 | chr14:40566961-40566962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs374317851 | chr14:40566991-40566992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs186969556 | chr14:40567050-40567051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs113985663 | chr14:40567051-40567052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs558854697 | chr14:40567082-40567083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs572602507 | chr14:40567087-40567088 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs573542767 | chr14:40567133-40567134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs111933700 | chr14:40567173-40567174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs553784670 | chr14:40567183-40567184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs573234755 | chr14:40567222-40567223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs368571594 | chr14:40567256-40567257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs112790111 | chr14:40567309-40567310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs724441 | chr14:40567324-40567325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs543446340 | chr14:40567336-40567337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs200498772 | chr14:40567343-40567344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs5808063 | chr14:40567345-40567346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs398077708 | chr14:40567348-40567349 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs397757415 | chr14:40567349-40567350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs200641215 | chr14:40567350-40567351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs563720246 | chr14:40567357-40567358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs183238621 | chr14:40567387-40567388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs539051676 | chr14:40567403-40567404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs559067085 | chr14:40567436-40567437 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs577037492 | chr14:40567446-40567447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs557633838 | chr14:40567458-40567459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Wilms tumour | 21544195 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 21298110 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 21858162 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Thyroid cancer | 19470727 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 21364760 | CNVD |
Intellectual disability | 22102821 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:40566400-40567200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
2 | chr14:40566400-40567600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr14:40568200-40569000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |